How is coronary artery ectasia classified according to severity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Classification of Coronary Artery Ectasia According to Severity

Coronary artery ectasia (CAE) is classified primarily using the Markis classification system, which stratifies severity based on the extent of coronary vessel involvement, ranging from Type 1 (diffuse ectasia in two or three vessels) to Type 4 (localized or segmental ectasia in a single vessel). 1, 2, 3

Defining Coronary Artery Ectasia

CAE is defined as abnormal dilation of a coronary artery segment ≥1.5 times the diameter of an adjacent normal reference segment 4, 5, 6. This threshold distinguishes ectasia from normal anatomical variation and mild dilation.

The Markis Classification System

The Markis classification is the most widely used severity grading system for CAE, categorizing patients into four types based on angiographic extent:

  • Type 1 (Most Severe): Diffuse ectasia involving two or three major coronary vessels
  • Type 2: Diffuse ectasia in one vessel and localized disease in another vessel
  • Type 3: Diffuse ectasia limited to one vessel only
  • Type 4 (Least Severe): Localized or segmental ectasia in a single vessel

Type 4 is the most commonly encountered pattern in clinical practice 3, though Type 1 carries the highest severity designation due to extensive multi-vessel involvement.

Alternative Classification: Harikrishnan System

Some centers also utilize the Harikrishnan classification, which provides additional granularity by incorporating the specific coronary territories affected. Type 4a in this system represents the most prevalent subtype 3.

Clinical Correlation with Severity

Research demonstrates that Markis Type 1 classification correlates with higher inflammatory markers (specifically elevated soluble CD40 ligand levels) compared to Types 3 and 4, suggesting more extensive disease activity 7. Additionally, patients with myocardial infarction without obstructive coronary artery disease (MINOCA) show significantly higher rates of Markis Class 1 ectasia (OR 5.08,95% CI 1.61-16.04) 1, indicating that extensive ectasia may represent a high-risk substrate even without stenotic disease.

Vessel-Specific Involvement

The frequency of arterial involvement follows this pattern:

  • Right coronary artery (RCA): 54.3%
  • Circumflex artery (Cx): 48.3%
  • Left anterior descending artery (LAD): 40.4%

Single-vessel involvement occurs in 64.2% of cases, while all three vessels are affected in only 9% 3.

Important Clinical Caveats

The severity classification based on anatomical extent does not always correlate directly with clinical risk. Isolated CAE without obstructive disease carries increased risk of myocardial infarction due to vasospasm, slower coronary blood flow, and thrombosis within dilated segments 4, even when classified as lower Markis types. Conversely, atherosclerotic CAE with concurrent obstructive disease does not appear to confer additional risk beyond the stenotic lesions themselves 4.

The Markis classification remains the standard for describing CAE severity in clinical practice and research, providing a reproducible framework for risk stratification and treatment planning 1, 2, 7, 3.

Related Questions

What is the difference between coronary ectasia and coronary aneurysm?
What is the appropriate medical management for a patient with basal inferior and posterior akinesia on echocardiogram after recent right coronary artery (RCA) stenting?
What are the differences between coronary artery aneurysm and coronary artery ectasia, and how should each be managed?
In a type 1 diabetic receiving parenteral nutrition (100 g dextrose with 19 U insulin) and continuous tube feeding (≈246 g carbohydrate per 24 h) who remains hyperglycemic despite NPH 20 U at 11 am and 20 U at 11 pm and now has infection with leukocytosis and fever, what NPH dose should be administered at 11 am and at 11 pm, and what insulin‑sensitivity factor should be used?
What is the definition (concept) of right-sided heart failure?
What is the recommended workup for a patient with multifocal pneumonia and a recent HIV diagnosis?
What are the causes of adrenal gland hemorrhage?
Which of the following statements about essential thrombocythemia is true?
Based on the echocardiogram showing a non‑dilated left ventricle with borderline reduced ejection fraction (45‑49 %), concentric wall thickening, mild mitral regurgitation, moderate functional tricuspid regurgitation, markedly enlarged right and left atria, right‑ventricular enlargement with severely reduced longitudinal function (tricuspid annular plane systolic excursion 6 mm, normal > 15 mm), interventricular septal flattening, and an estimated pulmonary artery pressure gradient of about 14 mmHg, what is the diagnosis and what management should be recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.